{
    "title": "Biogen readies for U.S. launch of Alzheimer's drug ahead of FDA meeting",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8863449/Biogen-cuts-year-profit-forecast-competition-MS-drug.html",
    "date": "2020-10-21",
    "keywords": [
        "drug",
        "approval",
        "biogen",
        "tecfidera",
        "aducanumab",
        "quarter",
        "roy",
        "launch",
        "vounatsos",
        "share",
        "inc",
        "wednesday",
        "part",
        "budget",
        "blockbuster",
        "sclerosis",
        "dominance",
        "threat",
        "drugmaker",
        "weight",
        "food",
        "panel",
        "meeting",
        "month",
        "executive",
        "officer",
        "michel",
        "decision",
        "march",
        "review",
        "japan",
        "vumerity",
        "study",
        "street",
        "latestage",
        "treatment",
        "progression",
        "disease",
        "pressure",
        "generic",
        "discount",
        "drop",
        "profit",
        "estimate",
        "revenue",
        "reporting",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}